Figure E - Secondary Antimicrobial Drug Used to Treat Gonorrhea among GISP Participants
This web page is archived for historical purposes and is no longer being updated. Newer data is available on the STD Data and Statistics page.
CLINIC | Percentage | ||
---|---|---|---|
Doxy/Tet | Azi/Ery | None/Other | |
ALBUQUERQUE | 0.9 | 98.2 | 0.9 |
ATLANTA | . | 97.3 | 2.7 |
BIRMINGHAM | 29.7 | 61.6 | 8.7 |
BOSTON | . | 92.3 | 7.7 |
BUFFALO | 1.2 | 97.6 | 1.2 |
CHICAGO | 0.8 | 97.6 | 1.6 |
CLEVELAND | 3.5 | 91.2 | 5.3 |
COLUMBUS | 3.1 | 91.5 | 5.4 |
DALLAS | 0.7 | 99.3 | . |
GREENSBORO | . | 100.0 | . |
HONOLULU | . | 99.2 | 0.8 |
INDIANAPOLIS | . | 95.7 | 4.3 |
KANSAS CITY | . | 99.1 | 0.9 |
LAS VEGAS | . | 100.0 | . |
LOS ANGELES | 1.2 | 93.6 | 5.3 |
MINNEAPOLIS | 1.0 | 96.1 | 2.9 |
NEW ORLEANS | . | 54.4 | 45.6 |
NEW YORK CITY | 3.0 | 90.2 | 6.8 |
ORANGE COUNTY | 1.2 | 94.7 | 4.1 |
PHILADELPHIA | 0.7 | 99.3 | . |
PHOENIX | 0.3 | 99.3 | 0.3 |
PONTIAC | 6.1 | 93.2 | 0.8 |
PORTLAND | 0.8 | 75.0 | 24.2 |
SAN DIEGO | . | 91.7 | 8.3 |
SAN FRANCISCO | 1.0 | 90.7 | 8.3 |
SEATTLE | 0.5 | 77.3 | 22.2 |
TRIPLER | 10.0 | 90.0 | . |
- Page last reviewed: July 15, 2016 (archived document)
- Content source: